Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006;67 Suppl 5:3-8.

Epidemiology, Clinical Consequences, and Psychosocial Treatment of Nonadherence in Schizophrenia

Affiliations
  • PMID: 16822090
Free article
Review

Epidemiology, Clinical Consequences, and Psychosocial Treatment of Nonadherence in Schizophrenia

Stefan Leucht et al. J Clin Psychiatry. .
Free article

Abstract

Partial adherence and nonadherence to medication continue to be problems in the treatment of patients with schizophrenia. Nonadherence to medication has a negative impact on the course of illness for these patients as is shown by data on relapse, rehospitalization, time to remission, and attempted suicide. Several factors that contribute to poor adherence have been identified and need to be taken into account when attempting to address the problem of nonadherence. These risk factors relate to the patient, his or her illness and social situation, and the physician. Among the measures that have the potential to improve adherence to medication are psychosocial interventions, psychoeducation in the form of professional, peer-to-peer or family-to-family interventions, and shared decision making.

Similar articles

See all similar articles

Cited by 47 articles

See all "Cited by" articles

MeSH terms

Substances

Feedback